Concourse Financial Group Securities’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10415 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10692 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10597 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10439 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10442 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10203 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9954 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9733 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9370 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9378 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 9183 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9012 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8800 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8479 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8002 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7610 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7265 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6944 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6684 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6514 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6404 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6319 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6167 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6153 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6022 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5936 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5777 |
|